Components of share-based compensation expense are as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(Unaudited, U.S. Dollars, in thousands)	2026		2025		2026		2025
Cost of sales	$	234	$	368	$	1,027	$	1,297
Sales, general, and administrative		6,102		6,448		18,824		19,012
Research and development		408		365		1,161		1,165
Total	$	6,744	$	7,181	$	21,012	$	21,474


	Three Months Ended September 30,				Nine Months Ended September 30,
(Unaudited, U.S. Dollars, in thousands)	2026		2025		2026		2025
Stock options	$	1,424	$	1,389	$	4,512	$	3,852
Market-based stock options		94		447		371		1,685
Time-based restricted stock units		3,128		3,371		9,594		9,893
Market-based / performance-based restricted stock units		1,766		1,585		5,389		4,655
Stock purchase plan		332		389		1,146		1,389
Total	$	6,744	$	7,181	$	21,012	$	21,474

During each of the three months ended September 30, 2026, and 2025, the Company issued fewer than 0.1 million shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises, and the vesting of restricted stock units. During the nine months ended September 30, 2026, and 2025, the Company issued 0.9 million and 1.0 million shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises, and the vesting of restricted stock units.